FdaApplication
NDA 020219
Identifiers
- fda_app_no: NDA020219
Properties
| Property | Value |
|---|---|
| applicant_name | NOVARTIS PHARMACEUTICALS CORP |
| application_type | NDA |
| approval_date | 1993-11-10 |
Products (1)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| LIVOSTIN | LEVOCABASTINE HYDROCHLORIDE | EQ 0.05% BASE | SUSPENSION/DROPS;OPHTHALMIC |
1 product